AMR.Solutions
Menu-01-01

July 14, 2022

WHO Vaccine pipeline review; CDC on impact of COVID on AMR

See also This related newsletter: 29 Mar 2021, entitled “Vaccines to turn back the tide of antimicrobial resistance.” This 20 Oct 2024 report from WHO: “Estimating the impact of vaccines in reducing antimicrobial resistance and antibiotic use: technical report” This 25 Apr 2024 paper in Lancet Global Health by Hausdorff and colleagues: “Facilitating the development

Read More »
14 July 2022 No Comments

IDWeek 2022: New pipeline sessions seek presentation of therapeutics and diagnostics!

Dear All: I have learned that the program for IDWeek 2022 will have specific dedicated pipeline sessions for therapeutics and diagnostics. The online details are relatively scant, but my understanding is that the therapeutics of interest for these sessions include antibacterials, antifungals, and non-HIV, non-COVID antiviral agents. There do not appear to be any constraints

Read More »
14 July 2022 No Comments
Scroll to Top